{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T15:25:46Z","timestamp":1795101946030,"version":"4.10.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100011776","name":"MND Scotland","doi-asserted-by":"publisher","award":["2021\/MNDS\/RP\/8430GILL"],"award-info":[{"award-number":["2021\/MNDS\/RP\/8430GILL"]}],"id":[{"id":"10.13039\/100011776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62351-3","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T04:51:59Z","timestamp":1754023919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The CCL2-CCR2 axis drives neuromuscular denervation in amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-0367","authenticated-orcid":false,"given":"Bern\u00e1t","family":"N\u00f3gr\u00e1di","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeka","family":"Krist\u00f3f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Horv\u00e1th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3936-5428","authenticated-orcid":false,"given":"Zara","family":"Ridgway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4782-6005","authenticated-orcid":false,"given":"Amaia","family":"Elicegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Fuertes-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3254-0365","authenticated-orcid":false,"given":"Sonia","family":"Alonso-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor J.","family":"Szebeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolett","family":"G\u00e9mes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3670-5881","authenticated-orcid":false,"given":"Hannah L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istv\u00e1n A.","family":"Krizbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Patai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Sikl\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-3266","authenticated-orcid":false,"given":"P\u00e9ter","family":"Kliv\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-7620","authenticated-orcid":false,"given":"Helena","family":"Chaytow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-5577","authenticated-orcid":false,"given":"Thomas H.","family":"Gillingwater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"62351_CR1","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1111\/ene.14393","volume":"27","author":"P Masrori","year":"2020","unstructured":"Masrori, P. & Van Damme, P. Amyotrophic lateral sclerosis: a clinical review. Eur. J. Neurol. 27, 1918\u20131929 (2020).","journal-title":"Eur. J. Neurol."},{"key":"62351_CR2","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrneurol.2013.221-c1","volume":"10","author":"MR Baker","year":"2014","unstructured":"Baker, M. R. ALS\u2014dying forward, backward or outward?. Nat. Rev. Neurol. 10, 660\u2013660 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"62351_CR3","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41973","volume":"7","author":"\u00c9 Martineau","year":"2018","unstructured":"Martineau, \u00c9, Di Polo, A., Vande Velde, C. & Robitaille, R. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. eLife 7, e41973 (2018).","journal-title":"eLife"},{"key":"62351_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13283","volume":"7","author":"F Tian","year":"2016","unstructured":"Tian, F. et al. Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging. Nat. Commun. 7, 13283 (2016).","journal-title":"Nat. Commun."},{"key":"62351_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","volume":"185","author":"LR Fischer","year":"2004","unstructured":"Fischer, L. R. et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185, 232\u2013240 (2004).","journal-title":"Exp. Neurol."},{"key":"62351_CR6","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41573-022-00612-2","volume":"22","author":"RJ Mead","year":"2023","unstructured":"Mead, R. J., Shan, N., Reiser, H. J., Marshall, F. & Shaw, P. J. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation. Nat. Rev. Drug Discov. 22, 185\u2013212 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"62351_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Xiao, D., Mao, Q. & Xia, H. Role of neuroinflammation in neurodegeneration development. Sig Transduct. Target Ther. 8, 1\u201332 (2023).","journal-title":"Sig Transduct. Target Ther."},{"key":"62351_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fneur.2020.00279","volume":"11","author":"PA McCombe","year":"2020","unstructured":"McCombe, P. A., Lee, J. D., Woodruff, T. M. & Henderson, R. D. The peripheral immune system and amyotrophic lateral sclerosis. Front. Neurol. 11, 279 (2020).","journal-title":"Front. Neurol."},{"key":"62351_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcaa124","volume":"2","author":"L-C B\u00e9land","year":"2020","unstructured":"B\u00e9land, L.-C. et al. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2, fcaa124 (2020).","journal-title":"Brain Commun."},{"key":"62351_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/mus.20376","volume":"32","author":"P Baron","year":"2005","unstructured":"Baron, P. et al. Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32, 541\u2013544 (2005).","journal-title":"Muscle Nerve"},{"key":"62351_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.552295","volume":"11","author":"R Tortelli","year":"2020","unstructured":"Tortelli, R. et al. Plasma inflammatory cytokines are elevated in ALS. Front. Neurol. 11, 552295 (2020).","journal-title":"Front. Neurol."},{"key":"62351_CR12","doi-asserted-by":"publisher","unstructured":"Olesen, M. N. et al. Inflammatory profiles relate to survival in subtypes of amyotrophic lateral sclerosis. Neurology - Neuroimmunology Neuroinflammation 7, https:\/\/doi.org\/10.1212\/NXI.0000000000000697 (2020).","DOI":"10.1212\/NXI.0000000000000697"},{"key":"62351_CR13","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1089\/jir.2008.0027","volume":"29","author":"SL Deshmane","year":"2009","unstructured":"Deshmane, S. L., Kremlev, S., Amini, S. & Sawaya, B. E. Monocyte chemoattractant protein-1 (MCP-1): An overview. J. Interferon Cytokine Res. 29, 313\u2013326 (2009).","journal-title":"J. Interferon Cytokine Res."},{"key":"62351_CR14","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock, B. J. et al. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 74, 1446\u20131454 (2017).","journal-title":"JAMA Neurol."},{"key":"62351_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jneuroim.2009.02.012","volume":"210","author":"S Mantovani","year":"2009","unstructured":"Mantovani, S. et al. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J. Neuroimmunol. 210, 73\u201379 (2009).","journal-title":"J. Neuroimmunol."},{"key":"62351_CR16","doi-asserted-by":"crossref","unstructured":"Beers, D. R. et al. ALS patients\u2019 regulatory T lymphocytes are dysfunctional, and correlate with disease progression rate and severity. JCI Insight 2, e89530 (2017).","DOI":"10.1172\/jci.insight.89530"},{"key":"62351_CR17","doi-asserted-by":"publisher","first-page":"e0182002","DOI":"10.1371\/journal.pone.0182002","volume":"12","author":"MP Gustafson","year":"2017","unstructured":"Gustafson, M. P. et al. Comprehensive immune profiling reveals substantial immune system alterations in a subset of patients with amyotrophic lateral sclerosis. PLOS ONE 12, e0182002 (2017).","journal-title":"PLOS ONE"},{"key":"62351_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.jns.2014.09.025","volume":"347","author":"X Chen","year":"2014","unstructured":"Chen, X. et al. Evidence for peripheral immune activation in amyotrophic lateral sclerosis. J. Neurological Sci. 347, 90\u201395 (2014).","journal-title":"J. Neurological Sci."},{"key":"62351_CR19","doi-asserted-by":"crossref","unstructured":"Trias, E. et al. Mast cells and neutrophils mediate peripheral motor pathway degeneration in ALS. JCI Insight 3, e123249 (2018).","DOI":"10.1172\/jci.insight.123249"},{"key":"62351_CR20","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.expneurol.2016.01.008","volume":"277","author":"JM Van Dyke","year":"2016","unstructured":"Van Dyke, J. M. et al. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS). Exp. Neurol. 277, 275\u2013282 (2016).","journal-title":"Exp. Neurol."},{"key":"62351_CR21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/joa.13463","volume":"241","author":"A Alhindi","year":"2022","unstructured":"Alhindi, A., Boehm, I. & Chaytow, H. Small junction, big problems: Neuromuscular junction pathology in mouse models of amyotrophic lateral sclerosis (ALS). J. Anat. 241, 1089\u20131107 (2022).","journal-title":"J. Anat."},{"key":"62351_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12925","volume":"49","author":"A Alhindi","year":"2023","unstructured":"Alhindi, A. et al. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 49, e12925 (2023).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"62351_CR23","doi-asserted-by":"publisher","first-page":"18809","DOI":"10.1073\/pnas.0908767106","volume":"106","author":"I Wegorzewska","year":"2009","unstructured":"Wegorzewska, I., Bell, S., Cairns, N. J., Miller, T. M. & Baloh, R. H. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. 106, 18809\u201318814 (2009).","journal-title":"Proc. Natl Acad. Sci."},{"key":"62351_CR24","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.nbd.2018.09.024","volume":"121","author":"D Gordon","year":"2019","unstructured":"Gordon, D. et al. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction. Neurobiol. Dis. 121, 148\u2013162 (2019).","journal-title":"Neurobiol. Dis."},{"key":"62351_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbi.2016.01.008","volume":"56","author":"MM Tetruashvily","year":"2016","unstructured":"Tetruashvily, M. M., McDonald, M. A. & Boulanger, L. M. MHCI promotes developmental synapse elimination and aging-related synapse loss at the vertebrate neuromuscular junction. Brain Behav. Immun. 56, 197\u2013208 (2016).","journal-title":"Brain Behav. Immun."},{"key":"62351_CR26","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a016303","volume":"7","author":"CL Sokol","year":"2015","unstructured":"Sokol, C. L. & Luster, A. D. The chemokine system in innate immunity. Cold Spring Harb. Perspect. Biol. 7, a016303 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"62351_CR27","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1046\/j.1365-2567.2002.01545.x","volume":"107","author":"WaC Sewell","year":"2002","unstructured":"Sewell, W.aC. & Jolles, S. Immunomodulatory action of intravenous immunoglobulin. Immunology 107, 387\u2013393 (2002).","journal-title":"Immunology"},{"key":"62351_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4049\/jimmunol.1701093","volume":"201","author":"\u00c1 Dom\u00ednguez-Soto","year":"2018","unstructured":"Dom\u00ednguez-Soto, \u00c1. et al. IVIg promote cross-tolerance against inflammatory stimuli in vitro and in vivo. J. Immunol. 201, 41\u201352 (2018).","journal-title":"J. Immunol."},{"key":"62351_CR29","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.tranon.2017.06.009","volume":"10","author":"M Yao","year":"2017","unstructured":"Yao, M., Smart, C., Hu, Q. & Cheng, N. Continuous delivery of neutralizing antibodies elevate CCL2 levels in mice bearing Mcf10ca1d breast tumor xenografts. Transl. Oncol. 10, 734\u2013743 (2017).","journal-title":"Transl. Oncol."},{"key":"62351_CR30","doi-asserted-by":"publisher","first-page":"200128","DOI":"10.1098\/rsos.200128","volume":"7","author":"G Minty","year":"2020","unstructured":"Minty, G. et al. aNMJ-morph: a simple macro for rapid analysis of neuromuscular junction morphology. R. Soc. Open Sci. 7, 200128 (2020).","journal-title":"R. Soc. Open Sci."},{"key":"62351_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200019","volume":"9","author":"JR Thonhoff","year":"2022","unstructured":"Thonhoff, J. R. et al. Combined regulatory T-Lymphocyte and IL-2 treatment is safe, tolerable, and biologically active for 1 year in persons with amyotrophic lateral sclerosis. Neurol. Neuroimmunol. Neuroinflammation 9, e200019 (2022).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"62351_CR32","doi-asserted-by":"publisher","first-page":"114378","DOI":"10.1016\/j.biopha.2023.114378","volume":"160","author":"AHME Ketabforoush","year":"2023","unstructured":"Ketabforoush, A. H. M. E. et al. Masitinib: The promising actor in the next season of the amyotrophic lateral sclerosis treatment series. Biomedicine Pharmacother. 160, 114378 (2023).","journal-title":"Biomedicine Pharmacother."},{"key":"62351_CR33","doi-asserted-by":"publisher","first-page":"E453","DOI":"10.1152\/ajpendo.00553.2012","volume":"304","author":"NJ Pillon","year":"2013","unstructured":"Pillon, N. J., Bilan, P. J., Fink, L. N. & Klip, A. Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am. J. Physiol.-Endocrinol. Metab. 304, E453\u2013E465 (2013).","journal-title":"Am. J. Physiol.-Endocrinol. Metab."},{"key":"62351_CR34","doi-asserted-by":"publisher","first-page":"9602","DOI":"10.1523\/JNEUROSCI.1736-20.2020","volume":"40","author":"C-Y Lu","year":"2020","unstructured":"Lu, C.-Y. et al. Macrophage-derived vascular endothelial growth factor-A is integral to neuromuscular junction reinnervation after nerve injury. J. Neurosci. 40, 9602\u20139616 (2020).","journal-title":"J. Neurosci."},{"key":"62351_CR35","doi-asserted-by":"publisher","first-page":"20960","DOI":"10.1073\/pnas.0911405106","volume":"106","author":"IM Chiu","year":"2009","unstructured":"Chiu, I. M. et al. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc. Natl Acad. Sci. 106, 20960\u201320965 (2009).","journal-title":"Proc. Natl Acad. Sci."},{"key":"62351_CR36","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0165-5728(02)00393-4","volume":"134","author":"D Orlikowski","year":"2003","unstructured":"Orlikowski, D. et al. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in guillain\u2013barr\u00e9 syndrome and experimental autoimmune neuritis. J. Neuroimmunol. 134, 118\u2013127 (2003).","journal-title":"J. Neuroimmunol."},{"key":"62351_CR37","doi-asserted-by":"publisher","first-page":"2760","DOI":"10.1016\/j.ymthe.2022.04.018","volume":"30","author":"MC Trolese","year":"2022","unstructured":"Trolese, M. C. et al. Boosting the peripheral immune response in the skeletal muscles improved motor function in ALS transgenic mice. Mol. Ther. 30, 2760\u20132784 (2022).","journal-title":"Mol. Ther."},{"key":"62351_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17620-8","volume":"11","author":"RS Blanc","year":"2020","unstructured":"Blanc, R. S. et al. Inhibition of inflammatory CCR2 signaling promotes aged muscle regeneration and strength recovery after injury. Nat. Commun. 11, 4167 (2020).","journal-title":"Nat. Commun."},{"key":"62351_CR39","doi-asserted-by":"publisher","first-page":"e12799","DOI":"10.1111\/nan.12799","volume":"48","author":"YM Arenas","year":"2022","unstructured":"Arenas, Y. M., Balzano, T., Ivaylova, G., Llansola, M. & Felipo, V. The S1PR2-CCL2-BDNF-TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia. Neuropathol. Appl. Neurobiol. 48, e12799 (2022).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"62351_CR40","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s12035-023-03641-z","volume":"61","author":"S Fang","year":"2024","unstructured":"Fang, S. et al. CCL2 Knockdown attenuates inflammatory response after spinal cord injury through the PI3K\/Akt signaling pathway: Bioinformatics analysis and experimental validation. Mol. Neurobiol. 61, 1433\u20131447 (2024).","journal-title":"Mol. Neurobiol."},{"key":"62351_CR41","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF02444000","volume":"243","author":"N Meucci","year":"1996","unstructured":"Meucci, N. & Nobile-Orazio, E. Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J. Neurol. 243, 117\u2013120 (1996).","journal-title":"J. Neurol."},{"key":"62351_CR42","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archneur.1994.00540210031010","volume":"51","author":"MC Dalakas","year":"1994","unstructured":"Dalakas, M. C. et al. Effect of high-dose intravenous immunoglobulin on amyotrophic lateral sclerosis and multifocal motor neuropathy. Arch. Neurol. 51, 861\u2013864 (1994).","journal-title":"Arch. Neurol."},{"key":"62351_CR43","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1073\/pnas.0912417107","volume":"107","author":"H Wils","year":"2010","unstructured":"Wils, H. et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. 107, 3858\u20133863 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"62351_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1093\/brain\/awh407","volume":"128","author":"FE Perrin","year":"2005","unstructured":"Perrin, F. E., Lacroix, S., Avil\u00e9s-Trigueros, M. & David, S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1\u03b1 and interleukin-1\u03b2 in Wallerian degeneration. Brain 128, 854\u2013866 (2005).","journal-title":"Brain"},{"key":"62351_CR45","doi-asserted-by":"crossref","unstructured":"Chaytow, H. et al. Targeting phosphoglycerate kinase 1 with terazosin improves motor neuron phenotypes in multiple models of amyotrophic lateral sclerosis. eBioMedicine 83, 104202 (2022).","DOI":"10.1016\/j.ebiom.2022.104202"},{"key":"62351_CR46","doi-asserted-by":"publisher","first-page":"1380481","DOI":"10.3389\/fimmu.2024.1380481","volume":"15","author":"E Szab\u00f3","year":"2024","unstructured":"Szab\u00f3, E. et al. Identification of immune subsets with distinct lectin binding signatures using multi-parameter flow cytometry: correlations with disease activity in systemic lupus erythematosus. Front. Immunol. 15, 1380481 (2024).","journal-title":"Front. Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62351-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62351-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T10:50:03Z","timestamp":1757328603000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62351-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62351"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62351-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.H.G. has provided advisory services for Roche and Novartis. S.A.-M. is a named inventor on a patent related to neurological disorders (PCT\/EP2021\/064274 and US 2024\/0277695 A1), entitled \u201cFOXO inhibitors for use in the treatment of diseases caused by abnormal processing of TDP-43 and\/or FUS proteins\u201d, not related to this study. SA-M also has ownership in Miaker Developments S.L., a startup related with a pipeline on Neurodegenerative and Neuromuscular Diseases. There are no other competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7053"}}